Skip to main content
Premium Trial:

Request an Annual Quote

Myriad and Abbott Extend Pharmacogenetics Pact

NEW YORK, Nov. 22 (GenomeWeb News) - Myriad Genetics and Abbott have extended a pharmacogenetics collaboration begun early last year, Myriad said today.


The collaboration will focus on identifying human genetic variation around drug targets in various stages of development, Myriad said.


Abbott will fund the research, and Myriad will use its sequencing technology and mutation screening software to analyze samples from various populations to identify genetic polymorphisms.


Financial details were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.